US: Microparticle-based Vaccines for Type 1 Diabetes at NIH

Font size: Decrease font Enlarge font

Position Description: The Keselowsky Lab, in partnership with the Diabetes Center of Excellence at UF, is seeking an enthusiastic Postdoctoral Associate to join the team working on an NIH-funded project on microparticle-based vaccines for type 1 diabetes. We are engineering polymeric biomaterials-based microparticles as an injectable vaccine system to retrain the immune system, correcting aberrant activation toward pancreatic self-antigens. Our approach is the targeted delivery of factors to dendritic cells, a key immune regulator, to effect antigen-specific, pro-tolerance modulation. Synthetic microparticles provide targeted, controlled delivery of encapsulated immunomodulatory factors and pancreatic antigen to dendritic cells in vivo, in order to promote tolerance for amelioration of diabetes.

Eligibility: Highly motivated applicants with a Ph.D. in engineering, materials science or a basic science are encouraged to apply. Relevant experience in biomaterials and/or immunology is preferred. Applicants should have a strong experimental background and publication record, as well as excellent verbal and written communication skills.

To Apply: Applicants must apply via Gator Jobs, jobs.ufl.edu: req #0T1076. Applicants should forward a cover letter, curriculum vitae, statement of research interests and contact information of three references to: bgk(at)ufl.edu

Benjamin Keselowsky, PhD
Associate Professor
J. Crayton Pruitt Family
Department of Biomedical Engineering
College of Engineering
PO Box 116131
Gainesville, FL 32611-6131
ufl.edu “>http://www.bme.ufl.edu/people/keselowsky_benjamin
bgk(at)ufl.edu

APPLICATION DEADLINE: August 31, 2013

Be Sociable, Share!

No Comments

Post your comment comment

You must be logged in to post a comment.